JP2017014155A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017014155A5 JP2017014155A5 JP2015133034A JP2015133034A JP2017014155A5 JP 2017014155 A5 JP2017014155 A5 JP 2017014155A5 JP 2015133034 A JP2015133034 A JP 2015133034A JP 2015133034 A JP2015133034 A JP 2015133034A JP 2017014155 A5 JP2017014155 A5 JP 2017014155A5
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- composition according
- protective composition
- retinal protective
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229930002945 all-trans-retinaldehyde Natural products 0.000 claims 7
- 230000001681 protective Effects 0.000 claims 7
- 230000002207 retinal Effects 0.000 claims 7
- 235000020945 retinal Nutrition 0.000 claims 7
- 239000011604 retinal Substances 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- MQZIGYBFDRPAKN-QISQUURKSA-N 6-hydroxy-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohexen-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,4,4-trimethylcyclohex-2-en-1-one Chemical compound CC=1C(=O)C(O)CC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(O)CC1(C)C MQZIGYBFDRPAKN-QISQUURKSA-N 0.000 claims 1
- 102100013988 CACFD1 Human genes 0.000 claims 1
- 101710023647 CACFD1 Proteins 0.000 claims 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 claims 1
- 229960002989 Glutamic Acid Drugs 0.000 claims 1
- 240000003613 Ipomoea batatas Species 0.000 claims 1
- 235000002678 Ipomoea batatas Nutrition 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- 235000010575 Pueraria lobata Nutrition 0.000 claims 1
- 244000046146 Pueraria lobata Species 0.000 claims 1
- 229920001800 Shellac Polymers 0.000 claims 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims 1
- 240000008536 Vaccinium myrtillus Species 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- 229940011671 Vitamin B6 Drugs 0.000 claims 1
- 229930003629 Vitamin B6 Natural products 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 229940046010 Vitamin K Drugs 0.000 claims 1
- 229930003448 Vitamin K Natural products 0.000 claims 1
- 229940019697 Vitamin K containing hemostatics Drugs 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000013793 astaxanthin Nutrition 0.000 claims 1
- 229940022405 astaxanthin Drugs 0.000 claims 1
- 239000001168 astaxanthin Substances 0.000 claims 1
- 235000015725 bilberry Nutrition 0.000 claims 1
- 150000001674 calcium compounds Chemical class 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001845 chromium compounds Chemical class 0.000 claims 1
- 125000003346 cobalamin group Chemical group 0.000 claims 1
- 229960004729 colecalciferol Drugs 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 235000014304 histidine Nutrition 0.000 claims 1
- 150000002506 iron compounds Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 235000006109 methionine Nutrition 0.000 claims 1
- 239000005078 molybdenum compound Substances 0.000 claims 1
- 150000002752 molybdenum compounds Chemical class 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 235000004400 serine Nutrition 0.000 claims 1
- 229940113147 shellac Drugs 0.000 claims 1
- 235000013874 shellac Nutrition 0.000 claims 1
- 239000004208 shellac Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 235000002374 tyrosine Nutrition 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
- 235000014393 valine Nutrition 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 150000003697 vitamin B6 derivatives Chemical class 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 1
- 235000005282 vitamin D3 Nutrition 0.000 claims 1
- 239000011647 vitamin D3 Substances 0.000 claims 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 1
- 229940021056 vitamin D3 Drugs 0.000 claims 1
- 235000019168 vitamin K Nutrition 0.000 claims 1
- 239000011712 vitamin K Substances 0.000 claims 1
- 150000003721 vitamin K derivatives Chemical class 0.000 claims 1
- 150000003752 zinc compounds Chemical class 0.000 claims 1
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015133034A JP6647809B2 (ja) | 2015-07-01 | 2015-07-01 | 網膜保護組成物 |
| JP2020004361A JP6978103B2 (ja) | 2015-07-01 | 2020-01-15 | 網膜保護組成物 |
| JP2021180408A JP7364252B2 (ja) | 2015-07-01 | 2021-11-04 | 網膜保護組成物 |
| JP2023164685A JP2023165886A (ja) | 2015-07-01 | 2023-09-27 | 網膜保護組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015133034A JP6647809B2 (ja) | 2015-07-01 | 2015-07-01 | 網膜保護組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020004361A Division JP6978103B2 (ja) | 2015-07-01 | 2020-01-15 | 網膜保護組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017014155A JP2017014155A (ja) | 2017-01-19 |
| JP2017014155A5 true JP2017014155A5 (es) | 2019-03-22 |
| JP6647809B2 JP6647809B2 (ja) | 2020-02-14 |
Family
ID=57829125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015133034A Active JP6647809B2 (ja) | 2015-07-01 | 2015-07-01 | 網膜保護組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6647809B2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019019072A (ja) * | 2017-07-14 | 2019-02-07 | 寿スピリッツ株式会社 | 網膜保護剤の製造方法および網膜保護剤 |
| WO2019151405A1 (ja) * | 2018-02-02 | 2019-08-08 | ニプロ株式会社 | 錠剤及びその製造方法 |
| JP7231232B2 (ja) * | 2020-03-31 | 2023-03-01 | 株式会社東洋新薬 | 経口組成物 |
| CN112544773A (zh) * | 2020-12-09 | 2021-03-26 | 光明乳业股份有限公司 | 一种冰淇淋原料组合物、冰淇淋及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003238442A (ja) * | 2002-02-19 | 2003-08-27 | Sunnyhealth Co Ltd | 眼健康指向性組成物 |
| US20140170247A1 (en) * | 2012-09-14 | 2014-06-19 | Guardion Health Sciences, Llc | Emulsion of Carotenoids and Ocular Antioxidants |
-
2015
- 2015-07-01 JP JP2015133034A patent/JP6647809B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020002271A (es) | Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas. | |
| PH12020550341A1 (en) | Niraparib formulations | |
| WO2016046260A8 (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
| MY193740A (en) | "substituted 2,4 diamino-quinoline as new anticancer agents" | |
| JP2017014155A5 (es) | ||
| EP3417853A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER CONTAINING POLYPHENOL COMPOUND AS ACTIVE INGREDIENT | |
| EP3176163A4 (en) | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | |
| EP3231436A4 (en) | Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient | |
| EP3604304A4 (en) | PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD OF MANUFACTURING AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES | |
| EP3138834A4 (en) | Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient | |
| WO2016074641A8 (zh) | Nadh或其盐在制备治疗苯丙酮尿症药物或保健品的应用 | |
| EP3352750A4 (en) | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | |
| EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| EP4311575A3 (en) | Methotrexate for proliferative vitreoretinopathy | |
| EP3248603A4 (en) | Pharmaceutical composition for prevention, treatment or delay of alzheimer's disease or dementia containing g protein-coupled receptor 19 agent as active ingredient | |
| JP2017008001A5 (es) | ||
| EP3643302A4 (en) | COMPOSITION COMPRISING A SESQUITERPENE DERIVATIVE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MUSCULAR DISEASES | |
| WO2015001541A3 (en) | Pharmaceutical film composition | |
| WO2016006974A3 (en) | Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof | |
| WO2016006975A3 (en) | Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof | |
| NZ767710A (en) | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | |
| JP2016210757A5 (es) | ||
| WO2015104666A3 (en) | Pharmaceutical composition of fingolimod | |
| EP3639817A4 (en) | COMPOSITIONS CONTAINING A PTEROSIN AND THEIR DERIVATIVES WHICH ARE ACTIVE INGREDIENTS IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF DEGENERATIVE BRAIN DISEASES | |
| PH12017550051A1 (en) | A pharmaceutical composition for treating gastrointestinal diseases |